AAAAAA

   
Results: 1-25 | 26-29 |
Results: 26-29/29
mu-Opioid receptor specific antagonist cyprodime: characterization by in vitro radioligand and [S-35]GTP gamma S binding assays
Authors: Marki, A Monory, K Otvos, F Toth, G Krassnig, R Schmidhammer, H Traynor, JR Roques, BP Maldonado, R Borsodi, A
Citation: A. Marki et al., mu-Opioid receptor specific antagonist cyprodime: characterization by in vitro radioligand and [S-35]GTP gamma S binding assays, EUR J PHARM, 383(2), 1999, pp. 209-214
Use of selective antagonists and antisense oligonucleotides to evaluate the mechanisms of BUBU antinociception
Authors: Hutcheson, DM Sanchez-Blazquez, P Rodriguez-Diaz, M Garzon, J Schmidhammer, H Borsodi, A Roques, BP Maldonado, R
Citation: Dm. Hutcheson et al., Use of selective antagonists and antisense oligonucleotides to evaluate the mechanisms of BUBU antinociception, EUR J PHARM, 383(1), 1999, pp. 29-37
Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with Delta-9-tetrahydrocannabinol
Authors: Hutcheson, DM Tzavara, ET Smadja, C Valjent, E Roques, BP Hanoune, J Maldonado, R
Citation: Dm. Hutcheson et al., Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with Delta-9-tetrahydrocannabinol, BR J PHARM, 125(7), 1998, pp. 1567-1577
Cerebral glucose metabolism during opioid withdrawal following methylnaloxonium injection into the locus coeruleus
Authors: Kimes, AS Maldonado, R Ambrosio, E Koob, GF London, ED
Citation: As. Kimes et al., Cerebral glucose metabolism during opioid withdrawal following methylnaloxonium injection into the locus coeruleus, BRAIN RES, 814(1-2), 1998, pp. 1-12
Risultati: 1-25 | 26-29 |